Dementia risk scores as surrogate outcomes for lifestyle‐based multidomain prevention trials—rationale, preliminary evidence and challenges
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Introduction: Although not designed as such, dementia risk scores might be useful surrogate outcomes for dementia prevention trials. Their suitability may be improved by using continuous scoring systems, taking into account all changes in risk factors, not only those crossing cut‐off values. Methods: In three large multidomain dementia prevention trials with 1.5 to 2 years of follow‐up (Multidomain Alzheimer Preventive Trial, Prevention of Dementia by Intensive Vascular Care and Healthy Ageing Through Internet Counselling in the Elderly) we assessed (1) responsiveness (sensitivity to change) and (2) actual and simulated intervention effects of the original and crude/weighted z‐score versions of the cardiovascular risk factors, aging and incidence of dementia, and Lifestyle for Brain Health scores. Results: All versions of the risk scores were generally responsive, and able to detect small though statistically significant between‐group differences after multidomain interventions. Simulated intervention effects were well detected in z‐score versions as well as in the original scores. Discussion: Dementia risk scores and their z‐score versions show potential as surrogate outcomes. How changes in risk scores affect dementia remains to be determined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Nichols, E., Szoeke, C. E. I., Vollset, S. E., Abbasi, N., Abd-Allah, F., Abdela, J., Aichour, M. T. E., Akinyemi, R. O., Alahdab, F., Asgedom, S. W., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30403-4 · Cited by 2,412
Andrieu, S., Guyonnet, S., Coley, N., Cantet, C., Bonnefoy, M., Bordes, S., Bories, L., Cufi, M.-N., Dantoine, T., Dartigues, J.-F., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30040-6 · Cited by 838
Self-citationAssociation Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
Gottesman, R. F., Schneider, A. L. C., Zhou, Y., Coresh, J., Green, E., Gupta, N., Knopman, D. S., Mintz, A., Rahmim, A., Sharrett, A. R., et al. (2017) · JAMA · doi:10.1001/jama.2017.3090 · Cited by 650
van Charante, E. P. M., Richard, E., Eurelings, L. S., van Dalen, J.-W., Ligthart, S. A., van Bussel, E. F., Hoevenaar-Blom, M. P., Vermeulen, M., & van Gool, W. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30950-3 · Cited by 611
Self-citationAndrieu, S., Coley, N., Lovestone, S., Aisen, P. S., & Vellas, B. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00153-2 · Cited by 293 · cited 1×
“The aims were to: (1) identify dementia risk scores that might be suitable as outcome measures for multidomain prevention trials conducted frommid-life onward; (2) propose methods to theoretically improve their responsiveness (sensitivity to change); (3) assess the responsiveness of (improved) risk scores in preventio…”
MethodSelf-citationWhy has therapy development for dementia failed in the last two decades?
Gauthier, S., Albert, M., Fox, N., Goedert, M., Kivipelto, M., Mestre‐Ferrandiz, J., & Middleton, L. T. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.003 · Cited by 238
Self-citationLifestyle for Brain Health (LIBRA): a new model for dementia prevention
Schiepers, O. J. G., Köhler, S., Deckers, K., Irving, K., O'Donnell, C. A., van den Akker, M., Verhey, F. R. J., Vos, S. J. B., de Vugt, M. E., & van Boxtel, M. P. J. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4700 · Cited by 208 · cited 1×
“for the different factors were derived from relative risks from published meta-analyses for each individual factor.(16,27) The full version includes 12 modifiable risk factors (Supplementary Table 3), giving a total score ranging from -4.”
MethodVos, S. J. B., van Boxtel, M. P. J., Schiepers, O. J. G., Deckers, K., de Vugt, M., Carrière, I., Dartigues, J.-F., Peres, K., Artero, S., Ritchie, K., et al. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161208 · Cited by 161
Akinyemi, R., Mukaetova-Ladinska, E., Attems, J., Ihara, M., & Kalaria, R. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990037 · Cited by 152
Cited by
Heger, I. S., Deckers, K., Schram, M. T., Stehouwer, C. D. A., Dagnelie, P. C., van der Kallen, C. J. H., Koster, A., Eussen, S. J. P. M., Jansen, J. F. A., Verhey, F. R. J., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012572 · Cited by 67
Dementia prevention: The potential long‐term cost‐effectiveness of the FINGER prevention program
Wimo, A., Handels, R., Antikainen, R., Eriksdotter, M., Jönsson, L., Knapp, M., Kulmala, J., Laatikainen, T., Lehtisalo, J., Peltonen, M., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12698 · Cited by 66
Self-citationColey, N., Giulioli, C., Aisen, P. S., Vellas, B., & Andrieu, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101777 · Cited by 62
Self-citationEggink, E., Hafdi, M., Hoevenaar-Blom, M. P., Song, M., Andrieu, S., Barnes, L. E., Birck, C., Brooks, R. L., Coley, N., Ford, E., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049762 · Cited by 37
Self-citationHeger, I., Deckers, K., de Vugt, M., Verhey, F., Oenema, A., van Boxtel, M., & Köhler, S. (2023) · Journal of Alzheimer’s Disease · doi:10.3233/jad-230225 · Cited by 20
“The LIBRA score, that was already used as a framework for a dementia risk reduction intervention discussed in a recent review, consists of 12 modifiable risk and protective factors for cognitive decline and dementia and has been extensively shown to predict dementia risk [21–23] and change in multimodal lifestyle inte…”
Method
Metadata
- Authors
- Coley, N., Hoevenaar‐Blom, M. P., van Dalen, J., Moll van Charante, E. P., Kivipelto, M., Soininen, H., Andrieu, S., Richard, E., & PRODEMOS consortium, T. P. S. G.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2020-08-16
- Volume
- 16
- Issue
- 12
- Pages
- 1674-1685
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W3049207482
- Cited by
- 45
- References
- 12
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dementia risk scores as surrogate outcomes for lifestyle‐based multidomain prevention trials—rationale, preliminary evidence and challenges. https://app.cochat.ai/papers/10.1002/alz.12169
- The paper
- Coley, N., Hoevenaar‐Blom, M. P., van Dalen, J., Moll van Charante, E. P., Kivipelto, M., Soininen, H., Andrieu, S., Richard, E., & PRODEMOS consortium, T. P. S. G. (2020). Dementia risk scores as surrogate outcomes for lifestyle‐based multidomain prevention trials—rationale, preliminary evidence and challenges. Alzheimer's & Dementia. https://doi.org/10.1002/alz.12169
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.